Dr. Heitham Abdul-Baki, MD

Dr. Abdul-Baki practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Abdul-Baki's NPI, 1790978542, was assigned on August 24, 2007. Dr. Abdul-Baki holds Pennsylvania license MD453130.

Dr. Abdul-Baki's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Abdul-Baki's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Abdul-Baki is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Abdul-Baki to 3 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdul-Baki practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Abdul-Baki's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Abdul-Baki is licensed in Pennsylvania.

CMS data shows 199 Medicare services from Dr. Abdul-Baki across 7 procedure codes in 2024, for 199 Medicare patients. Medicare paid $21,450 for them.

CMS counts 199 Medicare patients who saw Dr. Abdul-Baki in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdul-Baki's median patient age at 63, with 48% women.

In 2024, Dr. Abdul-Baki wrote 965 Medicare Part D claims for 287 patients. 67% of them were for generic drugs. CMS names the drug for 804 of them, across 21 drugs with 11 or more claims each, at $3,608,207 in total drug cost. In 2023, CMS named 563 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Abdul-Baki for performance year 2024, reported through an alternative payment model (APM). Dr. Abdul-Baki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdul-Baki as offering telehealth. CMS counts 46 procedures of colonoscopy by Dr. Abdul-Baki, more than 62% of the clinicians it reports for that procedure.

CMS Open Payments shows 168 general payments to Dr. Abdul-Baki from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Bristol-Myers Squibb Company paid the most, $37,899.